Arthritis News and Research

Latest Arthritis News and Research

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

The prevalence of skin disease exceeds that of obesity, hypertension or cancer. One in three individuals in the United States suffers with a skin disease, with ~2-3% of the American population suffering from psoriasis.

27 Sep 2013

Scientists discover critical regulator for directing pluripotent stem cells to make blood-forming stem cells

Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online today in Cell.

27 Sep 2013

Childhood abuse, lack of parental affection may increase health risk in adulthood

The effects of childhood abuse and lack of parental affection can last a lifetime, taking a toll both emotionally and physically.

27 Sep 2013

Scientists study genetic factors involved in complex diseases

Although heavily studied, the specific genetic causes of "complex diseases," a category of disorders which includes autism, diabetes and heart disease, are largely unknown due to byzantine genetic and environmental interactions.

27 Sep 2013

Continental Who's Who recognizes Thomas M. DeBerardino as Top Orthopedic Surgeon

Dr. Thomas M. DeBerardino, M.D. is recognized by Continental Who's Who as a Top Orthopedic Surgeon as a result of his vast success within the field of Sports Medicine. Dr. DeBerardino is an Associate Professor of Orthopedic Surgery with the University of Connecticut Health Center.

26 Sep 2013

$Repeating BMD tests after four years provides no clinical benefit of fracture risk in older adults$

Repeating BMD tests after four years provides no clinical benefit of fracture risk in older adults

Repeating bone mineral density (BMD) tests after four years provides little clinical benefit when assessing bone fracture risk in seniors age 75 and older, according to a recent study led by researchers at the Harvard Medical School-affiliated Institute for Aging Research at Hebrew SeniorLife. The study appears in the Sept. 25 online issue of JAMA.

25 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

Discovery could help develop new treatments for blood diseases

Researchers in Melbourne, Australia, have found that even our immune system is subject to performance enhancement, with our bodies giving immune cells the boost they need to ensure the best team is selected to fight infections.

24 Sep 2013

ACR journals publish guide that provides new treatments for children with systemic JIA

In the U.S., there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses according to estimates from the American College of Rheumatology (ACR). For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective treatment for this disabling disease is imperative.

24 Sep 2013

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

...

23 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Ablynx and AbbVie today announced that they have entered into a global license agreement to develop and commercialize the anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases.

23 Sep 2013

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

...

19 Sep 2013

Wearing back braces prevents need for spinal correction surgery in children with AIS

A multi-center study led by University of Iowa researchers to determine whether wearing back braces would prevent the need for spinal correction surgery in children with adolescent idiopathic scoliosis (AIS) was cut short when early results were overwhelmingly in favor of bracing.

19 Sep 2013

Parenting stress among caregivers of children with chronic illness: A systematic review

The extra demands on parents of chronically ill children cause stress that affects the whole family, according to a systematic review conducted by Case Western Reserve University researchers that also explored what factors in the child's care most contribute to the added strain.

19 Sep 2013

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

...

18 Sep 2013

Gout: An Interview with Dr. Lawrence Edwards, Chairman and CEO of GUAES

Gout is the most common form of inflammatory arthritis that affects adults. It's a disease caused by the presence of uric acid crystals in and around the joints. It's a disease that's becoming more and more common. It probably has doubled in its prevalence worldwide over the past twenty to thirty years.

18 Sep 2013

Comprehensive approach to the evaluation of groin pain

She wasn't born this way, but even Lady Gaga experienced groin pain-typically a symptom of hip disease such as arthritis of the hip-or, in her case, a hip labral tear. Groin pain is a common health complaint. According to a literature review appearing in the September 2013 issue of the Journal of the American Academy of Orthopaedic Surgeons, one in four people develop hip arthritis-damage to the surfaces in the hip joint-before the age of 85 that contributes to groin pain.

18 Sep 2013

SignaBlok's novel peptide inhibitor of TREM-1 suppresses cancer progression

SignaBlok, Inc., a Massachusetts-based biopharmaceutical company, today announced the successful in vivo proof of concept data that demonstrate that the company's novel mechanism-based, first-in-class peptide inhibitor of TREM-1 effectively suppresses cancer progression in mouse models of lung cancer and dramatically improves survival in septic mice.

18 Sep 2013

Arthritis News and Research

Latest Arthritis News and Research

Psoriasis and the nervous system: an interview with Dr Nicole Ward, Case Western Reserve University

Scientists discover critical regulator for directing pluripotent stem cells to make blood-forming stem cells

Childhood abuse, lack of parental affection may increase health risk in adulthood

Scientists study genetic factors involved in complex diseases

Continental Who's Who recognizes Thomas M. DeBerardino as Top Orthopedic Surgeon

Repeating BMD tests after four years provides no clinical benefit of fracture risk in older adults

Abbvie, Galapagos Ink Up To $405M CF Collaboration

Abbvie, Galapagos Ink Up To $405M CF Collaboration

Discovery could help develop new treatments for blood diseases

ACR journals publish guide that provides new treatments for children with systemic JIA

Abbvie, Ablynx Ink Up To $840M RA, SLE Collaboration

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

Wearing back braces prevents need for spinal correction surgery in children with AIS

Parenting stress among caregivers of children with chronic illness: A systematic review

GSK Returns Vercirnon Rights To Chemocentryx After Phase III Flop

Gout: An Interview with Dr. Lawrence Edwards, Chairman and CEO of GUAES

Comprehensive approach to the evaluation of groin pain

SignaBlok's novel peptide inhibitor of TREM-1 suppresses cancer progression

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Arthritis News and Research

Latest Arthritis News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in